beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.
about
Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signalingTissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumoursActivation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblastTargeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapyBeta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosisLiganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cellsTargeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancerWnt signalling and the mechanistic basis of tumour developmentDown-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomasCTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosisLoss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreas.In vivo selection for metastasis promoting genes in the mouseMitochondrial uncoupler exerts a synthetic lethal effect against β-catenin mutant tumor cellsWNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner.Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways.Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.The role of LEF1 in endometrial gland formation and carcinogenesisOvarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancersHereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Integrin regulation of beta-catenin signaling in ovarian carcinoma.Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growthPrognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomasOrigins and molecular pathology of ovarian cancer.Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms.Expression of Cyclin D1 Is Associated with β-Catenin Expression and Correlates with Good Prognosis in Colorectal Adenocarcinoma.High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivoTargeting Wnt pathways in disease.Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 proteinWnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta.Wnt signaling in ovarian tumorigenesis
P2860
Q24293496-1086116A-D0A5-44C8-AF6D-1820E9BE9A08Q24651981-14CEAE8C-537E-437C-9B45-A043A5998768Q24674988-ED688CDF-B09A-4451-9BC7-406573871297Q26775961-80612C26-F535-40CB-B7AF-070E7E1080D2Q27478444-9D77D5EA-DE9C-421A-A768-E259DCFC2334Q28210565-B87BA26A-D9E2-4AE6-93A8-7B8FFBC3ECB1Q28273722-9F67B279-8272-448B-B63D-B0DB91BA63EBQ28301804-123C0247-E1FE-4957-B3C3-6275A00E0D5BQ28359685-CA5FFB07-C280-476E-976A-E92356111AFFQ30684045-59CB1CDB-2F86-481F-9601-5C907825EAEFQ31011575-EB00EF66-8320-4F28-B957-75C3B2508F99Q33276528-8734C21B-73E5-49A7-A4AD-B93BB9F95AB7Q33281597-EC787542-79F6-4C6B-AC5D-517F71D9A47DQ33607603-D09388C0-42AD-44D7-A695-19FB0BCFCCC3Q33785885-15BDF88B-8555-46A9-B5B3-972A38CEB282Q33814311-73B36667-70B3-42E5-95D0-D6424BC187B1Q33890039-2ED4D974-84CF-413B-9FC0-4C3196A74DB6Q34133482-C80CF782-BC19-4D7C-824C-7811C7723E6DQ34336142-359DDC0B-6B62-4604-8BF5-DA6BFCCFF023Q34350701-12DFC2F6-9849-4937-B128-D17811F15EF5Q34435134-55571CBA-02E3-4709-A3D1-754F72FA79D9Q34977063-0BE45BB3-F54F-455D-BD4E-1ACA16F94B3AQ35067867-E784705E-01F7-42E6-9839-21742CCDA100Q35084738-93BE2BBB-7298-4B59-81C1-0A3D4B23B587Q35098085-B5F98B37-4000-4682-A149-379EFB325F96Q35118920-17E97C66-D5E6-40EB-93EE-E0FBDF327A53Q35140600-FE751226-B5AE-4444-8A08-E2650B5815B8Q35281886-BAEC8D17-B068-4DD7-BD63-72B52441CEAFQ35769582-C349B9BC-8431-42CA-A77C-A0A09C378EF9Q35788961-B7F751D8-EA90-4A06-B937-8A453482B3F9Q36068263-CB973367-8373-4644-984D-5709379E3651Q36116519-5BC37F98-6DF2-4C2F-9348-2F93499E389EQ36310657-9D552983-3269-4843-993C-BDA4A39E6C25Q36375053-63E8CFD3-0382-4F21-AF64-D049B4EC2AABQ36488720-CF385EC0-FAAF-4BA9-AC4C-5727B828F57BQ36506697-D4790035-11BA-4B68-A970-AE264199A74EQ36508547-13BB2164-6EED-4972-992D-EA8779B6C0C5Q36596332-403DF478-8B2A-49E7-B896-257DD2D217C3Q36671104-5A9F469E-3E0C-4101-BE79-B3C71BFE0445Q36953825-97C5A9FC-54CB-4C41-8BDA-C37C8CCAE254
P2860
beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
beta-catenin expression patter ...... eatures, and clinical outcome.
@ast
beta-catenin expression patter ...... eatures, and clinical outcome.
@en
type
label
beta-catenin expression patter ...... eatures, and clinical outcome.
@ast
beta-catenin expression patter ...... eatures, and clinical outcome.
@en
prefLabel
beta-catenin expression patter ...... eatures, and clinical outcome.
@ast
beta-catenin expression patter ...... eatures, and clinical outcome.
@en
P2093
P2860
P1476
beta-catenin expression patter ...... eatures, and clinical outcome.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65148-6
P407
P577
1999-08-01T00:00:00Z